Skip to Main content
Number of documents

29

Zoubida Karim


Journal articles29 documents

  • Maxime Touzot, Thibaud Lefebvre, Catherine Maheas, Christophe Ridel, Hervé Puy, et al.. A hepcidin‐based approach for iron therapy in hemodialysis patients: A pilot study. Hemodialysis International, Wiley, 2020, 24 (2), pp.188-194. ⟨10.1111/hdi.12823⟩. ⟨hal-03046316⟩
  • Jean-Marc Blouin, Cécile Ged, Magalie Lalanne, Isabelle Lamrissi-Garcia, Fanny Morice-Picard, et al.. Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria. Blood, American Society of Hematology, 2020, 136 (21), pp.2457-2468. ⟨10.1182/blood.2020006037⟩. ⟨hal-03045807⟩
  • Elisabeth Tybl, Hiromi Gunshin, Sanjay Gupta, Tomasa Barrientos, Michael Bonadonna, et al.. Control of Systemic Iron Homeostasis by the 3’ Iron-Responsive Element of Divalent Metal Transporter 1 in Mice. HemaSphere, Lippincott, Williams & Wilkins, 2020, 4 (5), pp.e459. ⟨10.1097/HS9.0000000000000459⟩. ⟨hal-03043109⟩
  • Sabrina Bondu, Anne-Sophie Alary, Carine Lefevre, Alexandre Houy, Grace Jung, et al.. A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome. Science Translational Medicine, American Association for the Advancement of Science, 2019, 11 (500), pp.eaav5467. ⟨10.1126/scitranslmed.aav5467⟩. ⟨inserm-02449216⟩
  • Katell Peoc'H, Gaël Nicolas, Caroline Schmitt, Arienne Mirmiran, Raed Daher, et al.. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. Molecular Genetics and Metabolism, Elsevier, 2019, ⟨10.1016/j.ymgme.2019.01.015⟩. ⟨hal-02351175⟩
  • Raed Daher, Abdellah Mansouri, Alain Martelli, Sophie Bayart, Hana Manceau, et al.. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia. Molecular Genetics and Metabolism, Elsevier, 2019, ⟨10.1016/j.ymgme.2018.12.012⟩. ⟨hal-02351427⟩
  • Sophie Park, Olivier Kosmider, Fréderic Maloisel, Bernard Drénou, Nicolas Chapuis, et al.. Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes. Haematologica, Ferrata Storti Foundation, 2019, 104 (3), pp.497-504. ⟨10.3324/haematol.2018.203158⟩. ⟨hal-02351432⟩
  • Maxime Touzot, Thibaud Lefebvre, Arthur Roux, Catherine Maheas, Christophe Ridel, et al.. Functional erythropoietin‐hepcidin axis in recombinant human erythropoietin independent haemodialysis patients. Nephrology, Wiley, 2019, 24 (7), pp.751-757. ⟨10.1111/nep.13485⟩. ⟨hal-02351435⟩
  • Zoubida Karim. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria). Biochemical and Biophysical Research Communications, Elsevier, In press, ⟨10.1016/j.bbrc.2019.09.141.⟩. ⟨hal-02350852⟩
  • Arienne Mirmiran, Caroline Schmitt, Thibaud Lefebvre, Hana Manceau, Raed Daher, et al.. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria. American Journal of Human Genetics, Elsevier (Cell Press), 2019, 104 (2), pp.341-347. ⟨10.1016/j.ajhg.2018.12.021⟩. ⟨hal-02328937⟩
  • Katell Peoc'H, Gaël Nicolas, Caroline Schmitt, Arienne Mirmiran, Raed Daher, et al.. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias. Molecular Genetics and Metabolism, Elsevier, 2019, ⟨10.1016/j.ymgme.2019.01.015⟩. ⟨inserm-02075450⟩
  • Raed Daher, Thibaud Lefebvre, Hervé Puy, Zoubida Karim. Extrahepatic hepcidin production: The intriguing outcomes of recent years. World Journal of Clinical Cases, 2019, 7 (15), pp.1926-1936. ⟨10.12998/wjcc.v7.i15.1926⟩. ⟨hal-02350928⟩
  • Raêd Daher, Thibaud Lefebvre, Hervé Puy, Zoubida Karim. Extrahepatic hepcidin production: The intriguing outcomes of recent years. World Journal of Clinical Cases, 2019, 7 (15), pp.1926-1936. ⟨10.12998/wjcc.v7.i15.1926⟩. ⟨hal-03046342⟩
  • Thibaud Lefebvre, Sarah Millot, Emmanuel Richard, Jean-Marc Blouin, Magalie Lalanne, et al.. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria). Biochemical and Biophysical Research Communications, Elsevier, 2019, 520 (2), pp.297-303. ⟨10.1016/j.bbrc.2019.09.141⟩. ⟨hal-03046353⟩
  • Camille Petillon, Rudolf Hergesheimer, Hervé Puy, Philippe Corcia, Patrick Vourc'H, et al.. The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls. Frontiers in Neuroscience, Frontiers, 2019, 12, pp.1031. ⟨10.3389/fnins.2018.01031⟩. ⟨hal-02351424⟩
  • Caroline Schmitt, Hugo Lenglet, Angèle Yu, Constance Delaby, Arndt Benecke, et al.. Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. Journal of Internal Medicine, Wiley, 2018, 284 (1), pp.78-91. ⟨10.1111/joim.12750⟩. ⟨hal-02503870⟩
  • Thibaud Lefebvre, Niloofar Reihani, Raed Daher, Thierry Billette de Villemeur, Nadia Belmatoug, et al.. Involvement of hepcidin in iron metabolism dysregulation in Gaucher disease. Haematologica, Ferrata Storti Foundation, 2018, 103 (4), pp.587-596. ⟨10.3324/haematol.2017.177816⟩. ⟨hal-02416875⟩
  • Katell Peoc'H, Hana Manceau, Zoubida Karim, Staffan Wahlin, Laurent Gouya, et al.. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword. Molecular Genetics and Metabolism, Elsevier, 2018, ⟨10.1016/j.ymgme.2018.10.001⟩. ⟨hal-02351428⟩
  • Jeremy Rouillon, Thibaud Lefebvre, Jérôme Denard, Vincent Puy, Raed Daher, et al.. High urinary ferritin reflects myoglobin iron evacuation in DMD patients. Neuromuscular Disorders, Elsevier, 2018, 28 (7), pp.564-571. ⟨10.1016/j.nmd.2018.03.008⟩. ⟨hal-02351437⟩
  • Hugo Lenglet, Caroline Schmitt, Thomas Grange, Hana Manceau, Narjesse Karboul, et al.. From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria. Human Molecular Genetics, Oxford University Press (OUP), 2018, 27 (7), pp.1164-1173. ⟨10.1093/hmg/ddy030⟩. ⟨hal-02351445⟩
  • Nicolas Pallet, Alexandre Karras, Eric Thervet, Laurent Gouya, Zoubida Karim, et al.. Porphyria and kidney diseases. Clinical Kidney Journal, Oxford University Press, 2018, 11 (2), pp.191-197. ⟨10.1093/ckj/sfx146⟩. ⟨hal-02351440⟩
  • Vincent Puy, Walaa Darwiche, Stephanie Trudel, Cathy Gomila, Christelle Lony, et al.. Predominant role of microglia in brain iron retention in Sanfilippo syndrome, a pediatric neurodegenerative disease. Glia, Wiley, 2018, 66 (8), pp.1709-1723. ⟨10.1002/glia.23335⟩. ⟨hal-02351442⟩
  • Mariane de Montalembert, Jean-Antoine Ribeil, Valentine Brousse, Agnès Guerci-Bresler, Aspasia Stamatoullas, et al.. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. PLoS ONE, Public Library of Science, 2017, 12 (3), pp.e0172147. ⟨10.1371/journal.pone.0172147⟩. ⟨hal-02377929⟩
  • Yvette Yien, Sarah Ducamp, Lisa van der Vorm, Julia Kardon, Hana Manceau, et al.. Mutation in human CLPX elevates levels of δ- aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria. Proceedings of the National Academy of Sciences of the United States of America , National Academy of Sciences, 2017, 114 (38), pp.E8045-E8052. ⟨10.1073/pnas.1700632114⟩. ⟨inserm-02075468⟩
  • Raed Daher, Hana Manceau, Zoubida Karim. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. La Presse Médicale, Elsevier Masson, 2017, 46 (12), pp.e272-e278. ⟨10.1016/j.lpm.2017.10.006⟩. ⟨hal-02351459⟩
  • Raed Daher, Caroline Kannengiesser, Dounia Houamel, Thibaud Lefebvre, Edouard Bardou-Jacquet, et al.. Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans. Gastroenterology, WB Saunders, 2016, 150 (3), pp.672-683. ⟨10.1053/j.gastro.2015.10.049⟩. ⟨hal-01231430⟩
  • Vincent Puy, Pierre-Edouard Bodet, Camille Rottier, Rémi Delaunay, Cathy Gomila, et al.. Corrigendum to “Alteration of cerebral iron metabolism in Sanfilippo syndrome” [Mol. Genet. Metab. 117 2, February 2016, p. S97]. Molecular Genetics and Metabolism, Elsevier, 2016, 118 (1), pp.64. ⟨10.1016/j.ymgme.2016.03.005⟩. ⟨hal-02065247⟩
  • Nicolas Pallet, Iadh Mami, Caroline Schmitt, Zoubida Karim, Arnaud François, et al.. High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria. Kidney International, Nature Publishing Group, 2015, 88 (2), pp.386-395. ⟨10.1038/ki.2015.97⟩. ⟨hal-02317945⟩
  • Saïd Lyoumi, Marie Abitbol, Dominique Rainteau, Zoubida Karim, Florence Bernex, et al.. Protoporphyrin retention in hepatocytes and kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.. Gastroenterology, WB Saunders, 2011, 141 ((4)), pp.1509-1519.e3. ⟨10.1053/j.gastro.2011.06.078⟩. ⟨hal-00631510⟩